Cuprina Holdings (Cayman) Ltd. (CUPR)
2.055
+0.12
(+6.48%)
USD |
NASDAQ |
Oct 21, 11:28
Cuprina Holdings Research and Development Expense (TTM) : 0.1734M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.1734M |
| June 30, 2025 | 0.2214M |
| Date | Value |
|---|---|
| December 31, 2024 | 0.1812M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 3.128B |
| Align Technology, Inc. | 377.00M |
| AngioDynamics, Inc. | 31.01M |
| Accuray, Inc. | 37.80M |
| Alphatec Holdings, Inc. | 76.69M |